HUMAN GENOME SCIENCES

Inactive Instrument

Human Genome Sciences Stock

Equities

US4449031081

Biotechnology & Medical Research

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2012	Actelion Ltd : Exclusive: Human Genome rejected Amgen's $7 billion bid in 2010: sources	RE
2012	BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion	RE

on all our subscriptions*

Take advantage of the offer

* See conditions on site

Latest news about Human Genome Sciences

Actelion Ltd : Exclusive: Human Genome rejected Amgen's $7 billion bid in 2010: sources	12-07-26	RE
BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion	12-07-16	RE
GlaxoSmithKline plc : Exclusive: GSK set for Human Genome takeover - sources	12-07-16	RE
GlaxoSmithKline plc : GSK in weekend talks to buy Human Genome: sources	12-07-15	RE
GlaxoSmithKline plc : GSK lines up nominees for Human Genome board	12-07-03	RE
GlaxoSmithKline plc : GSK further extends $2.6 billion Human Genome offer	12-06-29	RE
GlaxoSmithKline plc : GSK extends its $2.6 billion offer for Human Genome	12-06-08	RE
GlaxoSmithKline plc : Court denies request to curb Human Genome takeover defense	12-06-01	RE
Genmab A/S : Exclusive: GlaxoSmithKline eyes replacing Human Genome board	12-05-31	RE
GlaxoSmithKline plc : Exclusive: GSK eyes replacing Human Genome board	12-05-30	RE
GlaxoSmithKline plc : GSK to drop Human Genome bid if "poison pill" stands	12-05-23	RE
SANOFI : GSK goes hostile with $2.6 billion Human Genome offer	12-05-09	RE
Ardea Biosciences, Inc. : Biotech targets fight back as Big Pharma circles	12-05-02	RE
Ardea Biosciences, Inc. : Warner Chilcott to explore sale of company	12-04-30	RE
GlaxoSmithKline plc : GSK bid undervalues Human Genome, investor says	12-04-29	RE

Press releases Human Genome Sciences

Human Genome Sciences : ANNOUNCES REQUIRED OFFER TO REPURCHASE IN RESPECT OF ITS 3.00% CONVERTIBLE SENIOR NOTES DUE 2018	12-08-03	PU
Human Genome Sciences : Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Human Genome Sciences, Inc.	12-07-26	PR
Human Genome Sciences : Law Offices of Howard G. Smith Announces Investigation of Human Genome Sciences Inc. Board of Directors for Potential Breaches of Fiduciary Duty	12-07-19	BU
Human Genome Sciences : Law Office of Brodsky & Smith, LLC Announces Investigation of Human Genome Sciences, Inc.	12-07-17	PR
Human Genome Sciences : Ryan & Maniskas, LLP Announces Investigation of Human Genome Sciences Inc.	12-07-17	BU

More press releases

News in other languages on Human Genome Sciences

GSK rachète Human Genome pour 3,0 milliards de dollars	12-07-16
Human Genome : grimpe avec la nouvelle offre de GSK.	12-07-16
Les valeurs à suivre à Wall Street	12-07-16
Les valeurs à suivre aujourd'hui à Wall Street	12-07-16
Human Genome Sciences : GLAXOSMITHKLINE s'emparerait d'HUMAN GENOME pour 2,8 milliards	12-07-16

Company Profile

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
MODERNA, INC.	+29.03%	49.18B
IQVIA HOLDINGS INC.	-0.10%	42.11B
LONZA GROUP AG	+43.45%	40.37B
CELLTRION, INC.	-5.26%	28.85B
ICON PUBLIC LIMITED COMPANY	+11.48%	26.09B
ALNYLAM PHARMACEUTICALS, INC.	-22.74%	18.71B
BIO-TECHNE CORPORATION	+9.06%	13.26B
MEDPACE HOLDINGS, INC.	+30.01%	12.32B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.51%	11.99B

Other Biotechnology & Medical Research

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW